About us

The Company

Bactevo has built a Totally Integrated Medicines Engine which it is using to create new therapeutics both on its own and with selected Pharma partners. Bactevo provides a paradigm shift in the speed, efficiency and quality of drug discovery, and massively enhances safety profiling to improve clinical success. Bactevo is developing breakthrough medicines for the treatment of diseases which involve defects in mitochondrial function, including rare diseases such as MELAS and LHON, as well as diseases of the central nervous system such as Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS).

Management Team

David Williams
David Williams, PhD
Chief Executive Officer
Board of Directors, Management Team
Giorgio
Giorgio Reggiani, MBA
Chief Financial Officer
Board of Directors, Management Team
Alex Alanine
Alexander Alanine, PhD
Chief Operating Officer
Management Team
Thompson3
Nicki Thompson, PhD
Chief Business Officer
Management Team
John Wain
John Wain, Prof
Chief Scientific Officer
Board of Directors, Management Team

Scientific Advisory Board

Professor-Doug-Turnbull216
Sir Doug Turnbull
Advisory Board
Jane Osbourne
Jane Osbourn, PhD
Advisory Board
Nicholas_Turner2
Nicholas Turner, Prof
Advisory Board
MervynBibb_web
Mervyn Bibb, Prof
Advisory Board

Board of Directors

David Williams
David Williams, PhD
Chief Executive Officer
Board of Directors, Management Team
Giorgio
Giorgio Reggiani, MBA
Chief Financial Officer
Board of Directors, Management Team
Ian George
Ian George, PhD
Board of Directors
Tim Bullock
Tim Bullock
Board of Directors
John Wain
John Wain, Prof
Chief Scientific Officer
Board of Directors, Management Team